Transforming growth factor-β1 (10 ng ml−1) decreased ZO-2 and E-cadherin expression in scirrhous gastric cancer cells and increased myosin light chain-2 phosphorylation (p-myosin), but not in non-scirrhous gastric cancer cells. The gene discussed is MYL2; the disease is gastric cancer.